ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,499 | -22.0% | 3,223 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $25,010 | +108.4% | 3,223 | +37.8% | 0.00% | – |
| Q1 2022 | $12,000 | -64.7% | 2,339 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $34,000 | -30.6% | 2,339 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $49,000 | +48.5% | 2,339 | +25.8% | 0.00% | +100.0% |
| Q2 2021 | $33,000 | -28.3% | 1,859 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $46,000 | -27.0% | 1,859 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $63,000 | +231.6% | 1,859 | +141.7% | 0.00% | +200.0% |
| Q3 2020 | $19,000 | -26.9% | 769 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $26,000 | – | 769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |